SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Janus Living, Inc. (JAN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JAN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio22.91
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.56
Book Value / Share$0.00
Revenue / Share$1.12
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
SharesGrow IV$7.30 (-71.7%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-2.33 |
$111.84M |
$-2.72M |
-2.4% |
| 2016 |
$-1.17 |
$103.59M |
$-1.45M |
-1.4% |
| 2017 |
$0.10 |
$41.54M |
$118K |
0.3% |
| 2018 |
$-3.75 |
$36.79M |
$-5.61M |
-15.2% |
| 2019 |
$-6.78 |
$35.1M |
$-11.96M |
-34.1% |
| 2020 |
$-4.59 |
$33.87M |
$-8.5M |
-25.1% |
| 2021 |
$-6.35 |
$40.02M |
$-16.89M |
-42.2% |
| 2022 |
$1.14 |
$39.61M |
$3.59M |
9.1% |
| 2023 |
$-5.01 |
$0.00 |
$-20.06M |
- |
| 2024 |
$-0.56 |
$12.53M |
$-6.25M |
-49.8% |
